Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain.

The Journal of Spinal Cord Medicine Pub Date : 2022-03-01 Epub Date: 2020-03-17 DOI:10.1080/10790268.2020.1730109
Mendel Kupfer, Christopher S Formal
{"title":"Non-opioid pharmacologic treatment of chronic spinal cord injury-related pain.","authors":"Mendel Kupfer,&nbsp;Christopher S Formal","doi":"10.1080/10790268.2020.1730109","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> Spinal cord injury-related pain is often a severe debilitating condition that adversely affects the patient's physical health, psychological wellbeing and quality of life. Opioid medications have historically been prescribed to this population with great frequency. As opioid abuse disorder becomes an ever-worsening public health issue, more attention must be placed upon non-opioid options. This paper reviews non-opioid medications to be considered when treating spinal cord injury-related pain. The pertinent literature is reviewed, and the advantages and pitfalls of various medication options are discussed in the complicated context of the individual with a spinal cord injury.<b>Methods:</b> Peer-reviewed journal articles and medication package insert data are reviewed.<b>Results:</b>. The non-opioid medications with the greatest evidence for efficacy in the treatment of chronic spinal cord injury-related pain are drawn from the antiepileptic drug and antidepressant categories though the specific selection must be nuanced to the particular individual patient. More research is required to understand the role of calcitonin, lithium, and marijuana in treating spinal cord injury-related pain.<b>Conclusions:</b> The complex clinical situation of each individual patient must be weighed against the risks and benefits of each medication, as reviewed in this paper, to determine the ideal treatment strategy for chronic spinal cord injury-related pain.</p>","PeriodicalId":501560,"journal":{"name":"The Journal of Spinal Cord Medicine","volume":" ","pages":"163-172"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/10790268.2020.1730109","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Spinal Cord Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10790268.2020.1730109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: Spinal cord injury-related pain is often a severe debilitating condition that adversely affects the patient's physical health, psychological wellbeing and quality of life. Opioid medications have historically been prescribed to this population with great frequency. As opioid abuse disorder becomes an ever-worsening public health issue, more attention must be placed upon non-opioid options. This paper reviews non-opioid medications to be considered when treating spinal cord injury-related pain. The pertinent literature is reviewed, and the advantages and pitfalls of various medication options are discussed in the complicated context of the individual with a spinal cord injury.Methods: Peer-reviewed journal articles and medication package insert data are reviewed.Results:. The non-opioid medications with the greatest evidence for efficacy in the treatment of chronic spinal cord injury-related pain are drawn from the antiepileptic drug and antidepressant categories though the specific selection must be nuanced to the particular individual patient. More research is required to understand the role of calcitonin, lithium, and marijuana in treating spinal cord injury-related pain.Conclusions: The complex clinical situation of each individual patient must be weighed against the risks and benefits of each medication, as reviewed in this paper, to determine the ideal treatment strategy for chronic spinal cord injury-related pain.

慢性脊髓损伤相关疼痛的非阿片类药物治疗。
目的:脊髓损伤相关疼痛通常是一种严重的衰弱状态,对患者的身体健康、心理健康和生活质量产生不利影响。阿片类药物在历史上经常被开具给这一人群。随着阿片类药物滥用障碍成为一个日益恶化的公共卫生问题,必须更多地关注非阿片类药物的选择。本文综述了在治疗脊髓损伤相关疼痛时应考虑的非阿片类药物。本文回顾了相关文献,并在脊髓损伤个体的复杂背景下讨论了各种药物选择的优点和缺陷。方法:回顾同行评议的期刊文章和药物说明书资料。在治疗慢性脊髓损伤相关疼痛方面最有效的非阿片类药物来自抗癫痫药物和抗抑郁药物类别,尽管具体选择必须根据具体患者进行细致入微的区分。需要更多的研究来了解降钙素、锂和大麻在治疗脊髓损伤相关疼痛中的作用。结论:正如本文所述,必须权衡每位患者的复杂临床情况与每种药物的风险和益处,以确定慢性脊髓损伤相关疼痛的理想治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信